Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME

Clinical trial NCT05387837 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05387837
Sponsor: Ashvattha Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Diabetic Macular Edema

Start date: 2022-08-31
Primary completion: 2025-05-09
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.